Global High Blood Pressure Drugs (Hypertension) Market Survey and Trend Research 2018

September 2018 | 70 pages | ID: G5CF2FBFC57EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Eli Lilly, Pfizer, Bayer, Symplmed, Merck, Merck, Sanofi, Boryung, Reata Pharmaceuticals, Lung Biotechnology, Yuhan, Takeda, Alvogen etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 High Blood Pressure Drugs (Hypertension) Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 HIGH BLOOD PRESSURE DRUGS (HYPERTENSION) MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Eli Lilly (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Pfizer (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Bayer (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Symplmed (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Merck (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Merck (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Sanofi (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Boryung (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Reata Pharmaceuticals (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Lung Biotechnology (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Yuhan (Company Overview, Sales Data etc.)
4.12 Takeda (Company Overview, Sales Data etc.)
4.13 Alvogen (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global High Blood Pressure Drugs (Hypertension) Market 2012-2017, by Type, in USD Million
Table Global High Blood Pressure Drugs (Hypertension) Market Forecast 2018-2023, by Type, in USD Million
Table Eli Lilly Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
Table Pfizer Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)
Table Bayer Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Bayer (Sales Revenue, Cost, Gross Margin)
Table Symplmed Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Symplmed (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Merck Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Sanofi Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Sanofi (Sales Revenue, Cost, Gross Margin)
Table Boryung Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Boryung (Sales Revenue, Cost, Gross Margin)
Table Reata Pharmaceuticals Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Reata Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Lung Biotechnology Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Lung Biotechnology (Sales Revenue, Cost, Gross Margin)
Table Yuhan Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Yuhan (Sales Revenue, Cost, Gross Margin)
Table Takeda Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Takeda (Sales Revenue, Cost, Gross Margin)
Table Alvogen Overview List
Table High Blood Pressure Drugs (Hypertension) Business Operation of Alvogen (Sales Revenue, Cost, Gross Margin)
Table Global High Blood Pressure Drugs (Hypertension) Sales Revenue 2012-2017, by Companies, in USD Million
Table Global High Blood Pressure Drugs (Hypertension) Sales Revenue Share, by Companies, in USD Million
Table High Blood Pressure Drugs (Hypertension) Demand 2012-2017, by Application, in USD Million
Table High Blood Pressure Drugs (Hypertension) Demand Forecast 2018-2023, by Application, in USD Million
Table Global High Blood Pressure Drugs (Hypertension) Market 2012-2017, by Region, in USD Million
Table High Blood Pressure Drugs (Hypertension) Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure High Blood Pressure Drugs (Hypertension) Industry Chain Structure
Figure Global High Blood Pressure Drugs (Hypertension) Market Growth 2012-2017, by Type, in USD Million
Figure Global High Blood Pressure Drugs (Hypertension) Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region